Skip to main content
SpringerLink
Log in

Pheochromocytoma

  • Chapter
  • First Online:
A Case-Based Guide to Clinical Endocrinology

  • 1323 Accesses

Abstract

Pheochromocytoma is a rare cause of endocrine hypertension with potentially fatal consequences if left untreated. A high index of suspicion is required of clinicians due to the nonspecific nature of symptoms, the risk of significant morbidity and mortality if the diagnosis is missed, and the high frequency of associated familial disease. Symptomatic patients typically present with complaints consistent with sustained or intermittent catecholamine excess, although some pheochromocytomas may be clinically silent, particularly those diagnosed in the evaluation of adrenal incidentalomas. Plasma free metanephrines or 24-hour urine fractionated metanephrines are the initial screening tests of choice and, only if elevated, should be followed by imaging to localize the tumor. Treatment for a confirmed pheochromocytoma is urgent surgical resection; however blood pressure must be controlled preoperatively with α-blockers to prevent a hypertensive crisis. Following treatment, all patients with pheochromocytoma should undergo a clinical assessment for the associated familial syndromes and susceptibilities with subsequent genetic testing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Varounis C, Katsi V, Nihoyannopoulos P, Lekakis J, Tousoulis D. Cardiovascular hypertensive crisis: recent evidence and review of the literature. Front Cardiovasc Med. 2017;3:51. Published 2017 Jan 10. https://doi.org/10.3389/fcvm.2016.00051.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kim JH, Moon H, Noh J, Lee J, Kim SG. Epidemiology and prognosis of Pheochromocytoma/Paraganglioma in Korea: a Nationwide study based on the National Health Insurance Service. Endocrinol Metab (Seoul). 2020;35(1):157–64. https://doi.org/10.3803/EnM.2020.35.1.157.

    Article  Google Scholar 

  3. Berends AMA, Buitenwerf E, de Krijger RR, et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review. Eur J Intern Med. 2018;51:68–73. https://doi.org/10.1016/j.ejim.2018.01.015.

    Article  PubMed  Google Scholar 

  4. Schwartz GL. Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness. Endocrinol Metab Clin N Am. 2011;40(2):279–94.

    Article  Google Scholar 

  5. Young WF Jr. Endocrine hypertension. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams textbook of endocrinology. 12th ed. Philadelphia: Elsevier; 2011.

    Google Scholar 

  6. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Hassan Murad M, Naruse M, Pacak K, Young WF Jr. Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42.

    Article  CAS  Google Scholar 

  7. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in the diagnosis and management. Endocr Rev. 2004;25(2):309–40.

    Article  Google Scholar 

  8. Kota SK, Kota SK, Panda S, Modi KD. Pheochromocytoma: an uncommon presentation of an asymptomatic and biochemically silent adrenal incidentaloma. Malays J Med Sci. 2012;19(2):86–91.

    PubMed  Google Scholar 

  9. Sahdev A. Recommendations for the management of adrenal incidentalomas: what is pertinent for radiologist? Br J Radiol. 2017;90(1072):20160627. https://doi.org/10.1259/brj.20160627.

    Article  Google Scholar 

  10. Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr Pathol. 2012;23(1):4–14.

    Article  CAS  Google Scholar 

  11. Eisenhofer G. Screening for pheochromocytomas and paragangliomas. Curr Hypertens Rep. 2012;14(2):130–7.

    Article  CAS  Google Scholar 

  12. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K. Biochemical diagnosis of pheochromocytoma: how to distinguish true-from false-positive test results. J Clin Endocrinol Metab. 2003;88(6):2656–66.

    Article  CAS  Google Scholar 

  13. Eisenhofer G, Huysmans F, Pacek K, Walther MM, Sweep FC, Lenders JW. Plasma metanephrines in renal failure. Kidney Int. 2005;67(2):668–77.

    Article  CAS  Google Scholar 

  14. Peaston RT, Graham KS, Chambers E. Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma. Clin Chim Acta. 2010;411(7–8):546–52.

    Article  CAS  Google Scholar 

  15. Manger WM. The protean manifestations of pheochromocytoma. Harm Metal Res. 2009;41(9):658–63.

    Article  CAS  Google Scholar 

  16. Zelinka T, Eisenhofer G, Pacek K. Pheochromocytoma as a catecholamine-producing tumor: implications for clinical practice. Stress. 2007;10(2):195–203.

    Article  CAS  Google Scholar 

  17. Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin N Am. 2011;40(2):295–vii. https://doi.org/10.1016/j.ecl.2011.02.002.

    Article  CAS  Google Scholar 

  18. Lenders JWM, Eisenhofer G, Pacak K. Catecholamines and adrenergic receptors. In: Pacak K, Lenders JWM, Eisenhofer G, editors. Pheochromocytoma diagnosis, localization, and treatment. 1st ed. Blackwell Publishing; 2007.

    Google Scholar 

  19. O’Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical application of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15(5):426–44.

    Article  Google Scholar 

  20. Manger W, Gifford RW. The clinical and experimental pheochromocytoma. 2nd ed. Malden: Blackwell Science; 1996.

    Google Scholar 

  21. Petrák O, Klímová J, Mráz M, et al. Pheochromocytoma with adrenergic biochemical phenotype shows decreased GLP-1 secretion and impaired glucose tolerance. J Clin Endocrinol Metab. 2020;105(6):dgaa154. https://doi.org/10.1210/clinem/dgaa154.

    Article  Google Scholar 

  22. Pacek K, Eisenofer G, Ahlman H, Bornstein SR, Giminez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNichol AM, Tischler AS. Pheochromocytoma: recommendations for clinical practice from the first international symposium. Nat Clin Pract Rev. 2007;3(2):92–102.

    Google Scholar 

  23. Klby L, Bernhardt P, Levin-Jakobson AM, Johanson V, Wngberg B, Ahlman H, Forssell-Aronsson E, Nilsson O. Uptake of meta-iodobenzylguanidine in neuroendocrine tumors is mediated by vesicular monoamine transporters. Br J Cancer. 2003;89(7):1383–8.

    Article  Google Scholar 

  24. Young WF Jr. Endocrine hypertension: then and now. Endocr Pract. 2010;16(5):888–902.

    Article  Google Scholar 

  25. Castinetti F, Kroiss A, Kumar R, Pacak K, Taieb D. 15 years of paraganglioma: imaging and imaging-based treatment of pheochromocytoma and paraganglioma. Endoc Relat Cancer. 2015;22(4):T135–45. https://doi.org/10.1530/ERC-15-0175. Epub 2015 June 4

    Article  CAS  Google Scholar 

  26. Lentschener C, Gaujoux S, Tesniere A, Dousset B. Point of controversy: perioperative care of patients undergoing pheochromocytoma removal—time for a reappraisal? Eur J Endocrinol. 2011;165(3):365–73.

    Article  CAS  Google Scholar 

  27. Drr R, Lenders JWM, Hofbauer LC, Naumann B, Bornstein SR, Eisenhofer G. Pheochromocytoma-update on disease management. Ther Adv Endocrinol Metab. 2012;3(1):11–26.

    Article  Google Scholar 

  28. Berends AMA, Kerstens MN, Lenders JWM, Timmers HJLM. Approach to the patient: perioperative management of the patient with pheochromocytoma or sympathetic paraganglioma. J Clin Endocrinol Metab. 2020;105(9):dgaa441. https://doi.org/10.1210/clinem/dgaa441.

    Article  Google Scholar 

  29. Phitayakorn R, McHenry CR. Perioperative considerations in patients with adrenal tumors. J Surg Oncol. 2012;106(5):604–10.

    Article  Google Scholar 

  30. Nölting S, Ullrich M, Pietzsch J, et al. Current Management of Pheochromocytoma/Paraganglioma: a guide for the practicing clinician in the era of precision medicine. Cancers (Basel). 2019;11(10):1505. Published 2019 Oct 8. https://doi.org/10.3390/cancers11101505.

    Article  CAS  Google Scholar 

  31. Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev. 2003;24(4):539–53.

    Article  CAS  Google Scholar 

  32. Prys-Roberts C. Phaeochromocytoma-recent progress and its management. Br J Anaesth. 2000;85(1):44–57.

    Article  CAS  Google Scholar 

  33. Ramachandran R, Rewari V. Current perioperative management of pheochromocytomas. Indian J Urol. 2017;33(1):19–25. https://doi.org/10.4103/0970-1591.194781.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Krakoff LR, Garbowit D. Adreno-medullary hypertension: a review of syndromes, pathophysiology, diagnosis, and treatment. Clin Chem. 1991;37(10 Pt 2):1849–53.

    Article  CAS  Google Scholar 

  35. Kinney MA, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2012;16(3):359–69.

    Article  Google Scholar 

  36. James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.

    Google Scholar 

  37. Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Müssig K, Muresan M, Schffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plckinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HP, European-American Pheochromocytoma Study Group. Clinical predictors and algorithm for genetic diagnosis of pheochromocytoma patients. Clin Cancer Res. 2009;15(20):6378–85.

    Article  CAS  Google Scholar 

  38. Jimnez C, Cote G, Arnold A, Gagel RF. Review: should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab. 2006;91(8):2851–8.

    Article  Google Scholar 

  39. Levine A. Adrenal disorders. Springer International Publishing; 2018. p. 173–88.

    Book  Google Scholar 

  40. Fishbein L. Pheochromocytoma and Paraganglioma: genetics, diagnosis, and treatment. Hematol Oncol Clin North Am. 2016;30(1):135–50. https://doi.org/10.1016/j.hoc.2015.09.006.

    Article  PubMed  Google Scholar 

  41. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Pezkowska M, Szmigielski C, Eng C, Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459–66.

    Article  CAS  Google Scholar 

  42. Tischler AS, deKrijger RR. 15 years of paraganglioma: pathology of pheochromocytoma and paraganglioma. Endocr Relat Cancer. 2015;22:T123–33.

    Article  CAS  Google Scholar 

  43. Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2014;21:405–14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA

    Sarah A. Reda

  2. Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA

    Emily A. Japp & Alice C. Levine

  3. Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Yale New Haven Health, Stratford, CT, USA

    Sandi-Jo Galati

  4. Division of Cardiology, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA

    Lawrence R. Krakoff

Authors
  1. Sarah A. Reda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emily A. Japp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandi-Jo Galati
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lawrence R. Krakoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alice C. Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah A. Reda .

Editor information

Editors and Affiliations

  1. Thyroid Research Unit, Department of Medicine, Icahn School of Medicine at Mount Sinai and James J. Peters VA Medical Center, New York, NY, USA

    Terry F. Davies

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reda, S.A., Japp, E.A., Galati, SJ., Krakoff, L.R., Levine, A.C. (2022). Pheochromocytoma. In: Davies, T.F. (eds) A Case-Based Guide to Clinical Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-84367-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-84367-0_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-84366-3

  • Online ISBN: 978-3-030-84367-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation